CID 45054580

N-(2-(2-(3-(allyloxy)benzylidene)hydrazino)-2-oxoethyl)tetradecanamide

Structural Information

Molecular Formula
C26H41N3O3
SMILES
CCCCCCCCCCCCCC(=O)NCC(=O)N/N=C/C1=CC(=CC=C1)OCC=C
InChI
InChI=1S/C26H41N3O3/c1-3-5-6-7-8-9-10-11-12-13-14-18-25(30)27-22-26(31)29-28-21-23-16-15-17-24(20-23)32-19-4-2/h4,15-17,20-21H,2-3,5-14,18-19,22H2,1H3,(H,27,30)(H,29,31)/b28-21+
InChIKey
NSVRWAXJOMLSAD-SGWCAAJKSA-N
Compound name
N-[2-oxo-2-[(2E)-2-[(3-prop-2-enoxyphenyl)methylidene]hydrazinyl]ethyl]tetradecanamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

443.3148 Da
Monoisotopic Mass

7.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 444.32208 217.1
[M+Na]+ 466.30402 222.5
[M+NH4]+ 461.34862 220.0
[M+K]+ 482.27796 214.4
[M-H]- 442.30752 217.9
[M+Na-2H]- 464.28947 218.2
[M]+ 443.31425 217.4
[M]- 443.31535 217.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.